APA (7th ed.) Citation

Lumin Liao, Bohong Cen, Guoxian Li, Yuanyi Wei, Zhen Wang, Wen Huang, . . . Aimin Ji. (2021). A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Lumin Liao, Bohong Cen, Guoxian Li, Yuanyi Wei, Zhen Wang, Wen Huang, Shuai He, Yawei Yuan, and Aimin Ji. A Bivalent Cyclic RGD-siRNA Conjugate Enhances the Antitumor Effect of Apatinib via Co-inhibiting VEGFR2 in Non-small Cell Lung Cancer Xenografts. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Lumin Liao, et al. A Bivalent Cyclic RGD-siRNA Conjugate Enhances the Antitumor Effect of Apatinib via Co-inhibiting VEGFR2 in Non-small Cell Lung Cancer Xenografts. Taylor & Francis Group, 2021.